BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4061059)

  • 1. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy.
    Hammarbäck S; Bäckström T; Holst J; von Schoultz B; Lyrenäs S
    Acta Obstet Gynecol Scand; 1985; 64(5):393-7. PubMed ID: 4061059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse mood effects during postmenopausal hormone treatment in relation to personality traits.
    Björn I; Bäckström T; Lalos A; Sundström-Poromaa I
    Climacteric; 2006 Aug; 9(4):290-7. PubMed ID: 16857659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone effects during sequential hormone replacement therapy.
    Andréen L; Bixo M; Nyberg S; Sundström-Poromaa I; Bäckström T
    Eur J Endocrinol; 2003 May; 148(5):571-7. PubMed ID: 12720542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
    Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premenstrual syndrome--psychiatric or gynaecological disorder?
    Bäckström T; Hammarbäck S
    Ann Med; 1991 Dec; 23(6):625-33. PubMed ID: 1663771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
    Hammarbäck S; Damber JE; Bäckström T
    J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attempts of treatment of menopausal hemorrhage and functional hemorrhages of the preclimacteric period with oral gestagen].
    Higier J; Grzeniewski L
    Wiad Lek; 1968 Jan; 21(2):87-90. PubMed ID: 5675823
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.
    Magos AL; Brewster E; Singh R; O'Dowd T; Brincat M; Studd JW
    Br J Obstet Gynaecol; 1986 Dec; 93(12):1290-6. PubMed ID: 3801360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative mood changes during hormone replacement therapy: a comparison between two progestogens.
    Björn I; Bixo M; Nöjd KS; Nyberg S; Bäckström T
    Am J Obstet Gynecol; 2000 Dec; 183(6):1419-26. PubMed ID: 11120505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premenstrual syndrome in hysterectomized women: mood and physical symptom cyclicity.
    Metcalf MG; Livesey JH; Wells JE; Braiden V; Hudson SM; Bamber L
    J Psychosom Res; 1991; 35(4-5):555-67. PubMed ID: 1920183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
    Leather AT; Studd JW; Watson NR; Holland EF
    Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study.
    Walker A; Bancroft J
    Psychosom Med; 1990; 52(1):86-96. PubMed ID: 2305025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexuality and androgens in women with cyclical mood changes and pre-menstrual syndrome.
    Ekholm UB; Turkmen S; Hammarbäck S; Bäckström T
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):248-55. PubMed ID: 24387812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.
    Björn I; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström G; Bäckström T
    J Clin Endocrinol Metab; 2003 May; 88(5):2026-30. PubMed ID: 12727949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome.
    Hammarbäck S; Ekholm UB; Bäckström T
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):132-7. PubMed ID: 1897330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to estrogen challenge test in women with and without premenstrual dysphoria.
    Eriksson O; Bäckström T; Stridsberg M; Hammarlund-Udenaes M; Naessén T
    Psychoneuroendocrinology; 2006 May; 31(4):415-27. PubMed ID: 16359822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome.
    Cubeddu A; Bucci F; Giannini A; Russo M; Daino D; Russo N; Merlini S; Pluchino N; Valentino V; Casarosa E; Luisi S; Genazzani AR
    Psychoneuroendocrinology; 2011 May; 36(4):523-30. PubMed ID: 20933336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol.
    Nyberg S
    Contraception; 2013 Jun; 87(6):773-81. PubMed ID: 23121822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome.
    Seippel L; Bäckström T
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1988-92. PubMed ID: 9626129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.